| Dr Fareed Kannout, MD | |
|
4600 Towson Ave Ste 101-n, Fort Smith, AR 72901-7961 | |
| (479) 274-6900 | |
| (479) 648-3951 |
| Full Name | Dr Fareed Kannout |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 4600 Towson Ave Ste 101-n, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144242892 | NPI | - | NPPES |
| 127260001 | Medicaid | AR | |
| 110181109 | Other | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | E-0453 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Compassion Home Care, Inc | Stigler, OK | Home health agency |
| Kal Home Health, Inc | Pocola, OK | Home health agency |
| Encompass Health Home Health Of Eastern Oklahoma | Muskogee, OK | Home health agency |
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Baptist Health - Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Fort Smith Communities | 3870668510 | 273 |
News Archive
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online.
Some caregivers in rural Malawi have expressed a reluctance to begin antiretroviral therapy for children living with HIV because of a belief that their "bodies were too weak for pills and their blood was 'still raw,' but that as it 'ripened' with time, HIV-related opportunistic infections would leave them," according to a study presented this week at the 1st International HIV Social Science and Humanities Conference in Durban, South Africa, PlusNews reports.
Although telemedicine could improve the quality of life of patients with chronic liver diseases, viable home care systems are still lacking. Scientists working on the EU-project "d-LIVER" mean to remedy this situation. Initial results have now been released.
› Verified 5 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902073620 PECOS PAC ID: 3870668510 Enrollment ID: O20080814000789 |
News Archive
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online.
Some caregivers in rural Malawi have expressed a reluctance to begin antiretroviral therapy for children living with HIV because of a belief that their "bodies were too weak for pills and their blood was 'still raw,' but that as it 'ripened' with time, HIV-related opportunistic infections would leave them," according to a study presented this week at the 1st International HIV Social Science and Humanities Conference in Durban, South Africa, PlusNews reports.
Although telemedicine could improve the quality of life of patients with chronic liver diseases, viable home care systems are still lacking. Scientists working on the EU-project "d-LIVER" mean to remedy this situation. Initial results have now been released.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fareed Kannout, MD Po Box 3528, Fort Smith, AR 72913-3528 Ph: (479) 274-2000 | Dr Fareed Kannout, MD 4600 Towson Ave Ste 101-n, Fort Smith, AR 72901-7961 Ph: (479) 274-6900 |
News Archive
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.
The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online.
Some caregivers in rural Malawi have expressed a reluctance to begin antiretroviral therapy for children living with HIV because of a belief that their "bodies were too weak for pills and their blood was 'still raw,' but that as it 'ripened' with time, HIV-related opportunistic infections would leave them," according to a study presented this week at the 1st International HIV Social Science and Humanities Conference in Durban, South Africa, PlusNews reports.
Although telemedicine could improve the quality of life of patients with chronic liver diseases, viable home care systems are still lacking. Scientists working on the EU-project "d-LIVER" mean to remedy this situation. Initial results have now been released.
› Verified 5 days ago
Dr. David A Hebert, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7301 Rogers Ave, Fort Smith, AR 72903 Phone: 479-314-6000 | |
Christopher Brian Cross, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 | |
Fiorella Nawar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Fort Smith, AR 72901 Phone: 479-709-7402 | |
Charles Moussallem, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave, Suite 280, Fort Smith, AR 72901 Phone: 479-709-7480 Fax: 479-709-7479 | |
Dr. Jason Glenn Daily, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-4000 Fax: 479-274-4099 | |
Ongkarn Sarasombath, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2000 Fax: 479-274-2194 | |
Dr. Jacob K Joseph, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 |